Interpret them as complementary signals rather than interchangeable scores. Skewness helps indicate whether imbalance around the mean may affect how a clinical variable is summarized, whereas kurtosis draws attention to tail behavior and unusually extreme observations. Considering both can reveal distribution features that a single measure would miss during clinical data screening.
The calculation from standardized central moments focuses the assessment on distributional shape rather than the original measurement units. In practice, this gives researchers a compact pair of shape measures to review with clinical summary statistics and visualizations before deciding whether a dataset warrants additional screening or whether model assumptions require closer evaluation.
Extreme observations can influence the assessment of tail behavior, making kurtosis particularly relevant when clinical measurements contain unusually prominent values. Asymmetry can also affect how a variable is represented around its mean. Reviewing these signals together helps distinguish a potentially unbalanced distribution from one whose main concern is extreme-tail behavior, guiding subsequent screening.
Neither measure should be interpreted in isolation. A numerical value can flag an unusual distributional pattern, but visualizations and other summary statistics provide the context needed to judge whether the pattern reflects asymmetry, tail prominence, or possible outliers. This combined review reduces the risk of choosing analyses or drawing conclusions from a single diagnostic.
Begin by calculating skewness and kurtosis for the clinical variable, then examine the results with visualizations and other summary statistics. Use the combined evidence to screen for asymmetry, prominent extreme values, or outliers. Finally, consider whether the observed distribution supports the assumptions of the planned analysis or whether the analytical approach needs further review.
They can inform statistical planning by showing whether distributional features deserve attention before applying regression, analysis of variance, or other tests. The measures do not replace evaluation of the full dataset; instead, they provide shape-related evidence that complements assumption checks and helps researchers decide whether conclusions may depend on unusual clinical data patterns.
Patient measurements and laboratory results are direct settings for this assessment. Researchers can use the measures during data screening to identify distributions that may complicate summaries, expose potential outliers, or challenge assumptions in planned models. Interpreting the findings alongside plots and descriptive statistics strengthens the evaluation of whether subsequent clinical analyses are reliable.